Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MetCool ACS
NCT05305898Phase 3Recruiting
- Sponsor
- Military Institute of Medicine – National Research Institute
- Start
- Feb 2022
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metformin in acute coronary syndrome (ACS), sponsored by Military Institute of Medicine – National Research Institute. Started Feb 2022; status: recruiting.
02
Drugs
metformin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT05305898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05305898.